Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Short-term Neuropsychiatric Outcomes and Quality of Life in COVID-19 Survivors

View ORCID ProfileRaúl Méndez, Vicent Balanzá-Martínez, Sussy C. Luperdi, Itziar Estrada, Ana Latorre, Paula González-Jiménez, Laura Feced, Leyre Bouzas, Katheryn Yépez, Ana Ferrando, David Hervás, Enrique Zaldívar, Soledad Reyes, Michael Berk, Rosario Menéndez
doi: https://doi.org/10.1101/2020.09.23.20190090
Raúl Méndez
1Pneumology Department. La Fe University and Polytechnic Hospital. Valencia, Spain
2Respiratory Infections Research Group. Health Research Institute La Fe. Valencia, Spain
3University of Barcelona. Barcelona, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Raúl Méndez
  • For correspondence: mendez_rau@gva.es
Vicent Balanzá-Martínez
4Teaching Unit of Psychiatry and Psychological Medicine, Department of Medicine, University of Valencia, CIBERSAM, Valencia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sussy C. Luperdi
5Psychiatry Department. La Fe University and Polytechnic Hospital. Valencia, Spain
6University of Valencia. Valencia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Itziar Estrada
6University of Valencia. Valencia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana Latorre
2Respiratory Infections Research Group. Health Research Institute La Fe. Valencia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paula González-Jiménez
1Pneumology Department. La Fe University and Polytechnic Hospital. Valencia, Spain
2Respiratory Infections Research Group. Health Research Institute La Fe. Valencia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Feced
1Pneumology Department. La Fe University and Polytechnic Hospital. Valencia, Spain
2Respiratory Infections Research Group. Health Research Institute La Fe. Valencia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leyre Bouzas
1Pneumology Department. La Fe University and Polytechnic Hospital. Valencia, Spain
2Respiratory Infections Research Group. Health Research Institute La Fe. Valencia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katheryn Yépez
1Pneumology Department. La Fe University and Polytechnic Hospital. Valencia, Spain
2Respiratory Infections Research Group. Health Research Institute La Fe. Valencia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana Ferrando
1Pneumology Department. La Fe University and Polytechnic Hospital. Valencia, Spain
2Respiratory Infections Research Group. Health Research Institute La Fe. Valencia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Hervás
7Data Science, Biostatistics & Bioinformatics. Health Research Institute La Fe. Valencia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Enrique Zaldívar
1Pneumology Department. La Fe University and Polytechnic Hospital. Valencia, Spain
2Respiratory Infections Research Group. Health Research Institute La Fe. Valencia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Soledad Reyes
1Pneumology Department. La Fe University and Polytechnic Hospital. Valencia, Spain
2Respiratory Infections Research Group. Health Research Institute La Fe. Valencia, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Berk
8Deakin University, IMPACT – the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Geelong, Australia
9Orygen, The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, Florey Institute for Neuroscience and Mental Health and the Department of Psychiatry, The University of Melbourne, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosario Menéndez
1Pneumology Department. La Fe University and Polytechnic Hospital. Valencia, Spain
2Respiratory Infections Research Group. Health Research Institute La Fe. Valencia, Spain
6University of Valencia. Valencia, Spain
10Center for Biomedical Research Network in Respiratory Diseases (CIBERES). Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background The general medical impacts of coronavirus (COVID-19) are increasingly appreciated. However, its impact on neurocognitive, psychiatric health and quality of life (QoL) in survivors after the acute phase is poorly understood. We aimed to evaluate neurocognitive function, psychiatric symptoms, and QoL in COVID-19 survivors shortly after hospital discharge.

Methods This was a cross-sectional analysis of a prospective study of hospitalized COVID-19 survivors followed-up for 2 months after discharge. A battery of standardized instruments evaluating neurocognitive function, psychiatric morbidity, and QoL (mental and physical components) was administered by telephone.

Findings Of the 229 screened patients, 179 were included in the final analysis. Among survivors, the prevalence of moderately impaired immediate verbal memory and learning was 38%, delayed verbal memory (11.8%), verbal fluency (34.6%), and working memory (executive function) (6.1%), respectively. Moreover, 58.7% of patients had neurocognitive impairment in at least one function. Rates of positive screening for anxiety were 29.6%, depression (26.8%), and post-traumatic stress disorder (25.1%) respectively. In addition, 39.1% of the patients had psychiatric morbidity. Low QoL for physical and mental components was detected in 44.1% and 39.1% of patients, respectively. Delirium and stress-related symptoms increased approximately 4-fold the odds of developing neurocognitive impairment. Female gender and neurocognitive impairment diagnosis were related with an increase of 2.5 and 4.56- fold odds respectively of psychiatric morbidity.

Interpretation Hospitalized COVID-19 survivors showed a high prevalence of neurocognitive impairment, psychiatric morbidity, and poor QoL in the short-term. It is uncertain if these impacts persist over the long-term.

Competing Interest Statement

Dr. M. Berk reports grants from National Institute of Health, grants from Cooperative Research Centre, grants from Autism Foundation, grants from Cancer Council of Victoria, grants from Stanley Medical Research Foundation, grants from Medical Benefits Fund, grants from National Health and Medical Research Council, grants from Medical Research Futures Fund, grants from Beyond Blue, grants from Rotary Health, grants from A2 milk company, grants from Meat and Livestock Board, grants from Woolworths, grants from Avant and the Harry Windsor Foundation, non-financial support from Astra Zeneca, non-financial support from Lundbeck, non-financial support from Merck, other from Pfizer, other from Allergan, other from Astra Zeneca, other from Bioadvantex, other from Bionomics, other from Collaborative Medicinal Development, other from Lundbeck, other from Merck, other from Pfizer, other from Servier, outside the submitted work.

Funding Statement

There was non-specific funding for this study

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Biomedical Research Ethics Committee of La Fe University and Polytechnic Hospital reviewed and approved the study (2020-280-1)

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data are accessible upon reasonable request

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted September 23, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Short-term Neuropsychiatric Outcomes and Quality of Life in COVID-19 Survivors
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Short-term Neuropsychiatric Outcomes and Quality of Life in COVID-19 Survivors
Raúl Méndez, Vicent Balanzá-Martínez, Sussy C. Luperdi, Itziar Estrada, Ana Latorre, Paula González-Jiménez, Laura Feced, Leyre Bouzas, Katheryn Yépez, Ana Ferrando, David Hervás, Enrique Zaldívar, Soledad Reyes, Michael Berk, Rosario Menéndez
medRxiv 2020.09.23.20190090; doi: https://doi.org/10.1101/2020.09.23.20190090
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Short-term Neuropsychiatric Outcomes and Quality of Life in COVID-19 Survivors
Raúl Méndez, Vicent Balanzá-Martínez, Sussy C. Luperdi, Itziar Estrada, Ana Latorre, Paula González-Jiménez, Laura Feced, Leyre Bouzas, Katheryn Yépez, Ana Ferrando, David Hervás, Enrique Zaldívar, Soledad Reyes, Michael Berk, Rosario Menéndez
medRxiv 2020.09.23.20190090; doi: https://doi.org/10.1101/2020.09.23.20190090

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Respiratory Medicine
Subject Areas
All Articles
  • Addiction Medicine (228)
  • Allergy and Immunology (504)
  • Anesthesia (110)
  • Cardiovascular Medicine (1238)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (531)
  • Epidemiology (10021)
  • Forensic Medicine (5)
  • Gastroenterology (499)
  • Genetic and Genomic Medicine (2453)
  • Geriatric Medicine (238)
  • Health Economics (479)
  • Health Informatics (1643)
  • Health Policy (752)
  • Health Systems and Quality Improvement (636)
  • Hematology (248)
  • HIV/AIDS (533)
  • Infectious Diseases (except HIV/AIDS) (11864)
  • Intensive Care and Critical Care Medicine (626)
  • Medical Education (252)
  • Medical Ethics (75)
  • Nephrology (268)
  • Neurology (2280)
  • Nursing (139)
  • Nutrition (352)
  • Obstetrics and Gynecology (454)
  • Occupational and Environmental Health (536)
  • Oncology (1245)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (157)
  • Palliative Medicine (50)
  • Pathology (324)
  • Pediatrics (730)
  • Pharmacology and Therapeutics (313)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2280)
  • Public and Global Health (4833)
  • Radiology and Imaging (837)
  • Rehabilitation Medicine and Physical Therapy (491)
  • Respiratory Medicine (651)
  • Rheumatology (285)
  • Sexual and Reproductive Health (238)
  • Sports Medicine (227)
  • Surgery (267)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)